inotuzumab

Definition of inotuzumab ozogamicin
National Cancer Institute

inotuzumab ozogamicin

(ih-noh-TOO-zoo-mab OH-zoh-ga-MIH-sin)
A drug used to treat adults with B-cell acute lymphoblastic leukemia that has come back or has not gotten better with other treatment. It is also being studied in the treatment of other types of cancer. Inotuzumab ozogamicin contains a monoclonal antibody that binds to a protein called CD22, which is found on some leukemia cells. It also contains an anticancer drug, which may help kill cancer cells. Inotuzumab ozogamicin is a type of antibody-drug conjugate. Also called Besponsa.

Source: NCI Dictionary of Cancer Terms